Skip to main content
Log in

XIAP expression and its predictive significance of prognosis in stage IIB osteosarcomas

  • Published:
The Chinese-German Journal of Clinical Oncology

Abstract

Objective

To evaluate X-linked inhibitor of apoptosis protein (XIAP) expression in biopsy specimens from the patients with stage IIB osteosarcomas before chemotherapy to study XIAP expression and its predictive significance of prognosis in stage IIB osteosarcomas.

Methods

The expression of XIAP was retrospectively detected by SP immunohistochemistry in 31 cases biopsy specimens from stage IIB osteosarcomas before chemotherapy, and the relationship between XIAP expression and clinicopathologic features of the patients with stage IIB osteosarcomas was analyzed.

Results

The osteosarcoma specimens showed strong cell nucleus immunoreaction of XIAP while normal bone specimens showed weak. High XIAP positive expression independently predicted the patient’s poor outcome and had no relationship with clinicopathologic variables such as age, gender, location, tumor size, rate of tumor necrosis to preoperative chemotherapy, local recurrence (P > 0.05). Significant correlations were found between high XIAP expression and metastasis (P = 0.022), and also between high XIAP expression and final survival (P = 0.011).

Conclusion

XIAP plays an important role in the development of stage IIB osteosarcomas and XIAP expression of biopsy specimens before chemotherapy can be seen as a promising prognostic marker in early predicting the outcome of patients suffering from stage IIB osteosarcomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Eckelman BP, Salvesen GS, Scott FL. Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family. EMBO Rep, 2006, 7: 988–994.

    Article  PubMed  CAS  Google Scholar 

  2. Liu JH, Li M, Xia SJ. Expression and clinical significance of antiapoptosis gene XIAP in prostate cancer. Nat J Androl (Chinese), 2004, 10: 832–835.

    CAS  Google Scholar 

  3. Li M, Song T, Yin ZF, et al. XIAP as a prognostic marker of early recurrence of nonmuscular invasive bladder cancer. Chin Med J, 2007, 120: 469–473.

    PubMed  CAS  Google Scholar 

  4. Qin YM, Auh S, Blokh L, et al. TNF-α induces transient resistance to Fas-induced apoptosis in eosinophilic acute myeloid leukemia cells. Cell Mol Immunol, 2007, 4: 43–52.

    PubMed  CAS  Google Scholar 

  5. Jian ZY, Li YX, Lu XG, et al. Expression of X-linked inhibitor of apoptosis in pancreatic carcinoma tissues and its relationship to chemoresistance. Chin J Digest (Chinese), 2006, 26: 76–79.

    CAS  Google Scholar 

  6. Meyers PA, Heller G, Healey J, et al. Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience. J Clin Oncol, 1992, 10: 5–15.

    PubMed  CAS  Google Scholar 

  7. Kim MS, Song WS, Cho WH, et al. Ezrin expression predicts survival in stage IIB osteosarcomas. Clin Orthop Relat Res, 2007, 459: 229–236.

    Article  PubMed  Google Scholar 

  8. Meyers PA, Schwartz CL, Krailo M, et al. Osteosarcoma: a randomized, prospective trail of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. J Clin Oncol, 2005, 23: 2004–2011.

    Article  PubMed  CAS  Google Scholar 

  9. Hornicek FJ, Gebhardt MC, Wolfe MW, et al. P-glycoprotein levels predict poor outcome in patients with osteosarcoma. Clin Orthop Relat Res, 2000, 373: 11–17.

    Article  PubMed  Google Scholar 

  10. Onda M, Matsuda S, Higaki S, et al. ErbB-2 expression is correlated with poor prognosis for patients with osteosarcoma. Cancer, 1996, 77: 71–78.

    Article  PubMed  CAS  Google Scholar 

  11. Serra M, Scotlandi K, Reverter-Branchat G, et al. Value of P-glycoprotein and clinicopathologic factors as the basis for new treatment strategies in high-grade osteosarcoma of the extremities. J Clin Oncol, 2003, 21: 536–542.

    Article  PubMed  CAS  Google Scholar 

  12. Woodhouse EC, Chuaqui RF, Liotta LA. General mechanisms of metastasis. Cancer, 1997, 80: 1529–1537.

    Article  PubMed  CAS  Google Scholar 

  13. Yang YF, Zhang GM, Xu ZH, et al. Repair of massive bone defects in limbs by using vascularized free fibular autograft compounding massive bone allografts. Chin J Repar Recons Surg (Chinese), 2005, 19: 986–988.

    Google Scholar 

  14. Yang YF, Zhang GM, XU ZH, et al. Structural bone allografts with intramedullary vascularized fibular autografts for the treatment of massive bone defects in extremities. J Med Coll PLA, 2007, 22: 298–302.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yunfa Yang.

Additional information

Supported by a grant from the Foundation for Scientific Research of Medical Science of Guangzhou (No. 2006-YB-017).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yang, Y., Du, H., Huang, P. et al. XIAP expression and its predictive significance of prognosis in stage IIB osteosarcomas. Chin. -Ger. J. Clin. Oncol. 7, 416–419 (2008). https://doi.org/10.1007/s10330-008-0024-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10330-008-0024-0

Key words

Navigation